Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
Background:Certolizumab pegol is used to treat ankylosing spondylitis, Crohn’s disease, psoriatic arthritis, and rheumatoid arthritis. Unlike other monoclonal antibodies such as infliximab and adalimumab, certolizumab does not contain an Fc fraction and hence does not induce complement activation. I...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Trakya University
2018-09-01
|
| Series: | Balkan Medical Journal |
| Assuntos: | |
| Acceso en liña: |
http://balkanmedicaljournal.org/archives/archive-detail/article-preview/drug-nduced-thrombotic-microangiopathy-with-certol/19696
|
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|